じん肺の世界市場レポート 2025年

じん肺市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.0％で76億2,000万米ドルに成長します。予測期間中に予測される成長の原動力は、労働衛生基準への注目の高まり、粉塵規制の厳格化、労働者の安全対策への投資の増加、じん肺リスクに対する意識の高まり、早期診断サービスへのアクセスの改善です。予測期間中に予想される主要動向には、肺画像技術の進歩、ポータブル呼吸器デバイスの革新、AIによる疾患検出の開発、粉塵関連の健康問題に対する研究開発資金の増加、ウェアラブル大気質モニタリングセンサの進歩などがあります。

喫煙の普及がじん肺市場の成長を促進すると予想されます。喫煙には、タバコ、葉巻、パイプなどのタバコ製品を燃やした煙を吸ったり吐いたりすることが含まれ、肺、心臓、健康全般に悪影響を及ぼす有害な化学品を放出します。喫煙率の上昇は、さまざまな年齢層でニコチン依存症が増加し、タバコを使用し続けることにつながっています。喫煙は、喫煙に関連する肺疾患の発生率を高めることで、じん肺の一因となっています。例えば、2023年6月にガーディアン紙が報じたところによると、英国では2023年初頭に14歳から17歳の14.5％がベイプ製品を使用しており、2022年の11.8％から増加しています。この喫煙率の増加がじん肺市場を前進させています。

ヘルスケア支出の増加がじん肺市場の成長に寄与すると予想されます。ヘルスケア支出は、個人、政府、組織による医療サービス、治療、健康関連製品への総支出です。ヘルスケア支出の増加は主に、継続的な治療と管理を必要とする慢性疾患の罹患率の増加によるものです。これらの支出は、早期診断、継続的な医療、呼吸療法、専門的な治療や薬へのアクセスに資金を提供することで、じん肺の治療を支えています。例えば、国家統計局が2024年5月に報告したところによると、英国のヘルスケア支出は2022～2023年にかけて5.6％増となり、2022年の0.9％増に比べて大幅に増加しました。したがって、ヘルスケア支出の増加はじん肺市場の成長を加速させると考えられます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のじん肺 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のじん肺市場：成長率分析
• 世界のじん肺市場の実績：規模と成長、2019～2024年
• 世界のじん肺市場の予測：規模と成長、2024～2029年、2034年
• 世界のじん肺総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のじん肺市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• アスベスト症
• ベリリオシス
• 綿肺症
• 炭鉱労働者じん肺
• 珪肺症
• その他
• 世界のじん肺市場治療別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬
• 酸素療法
• 肺リハビリテーション
• その他
• 世界のじん肺市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 吸入
• その他
• 世界のじん肺市場：診断方法別、実績と予測、2019～2024年、2024～2029年、2034年
• 胸部X線写真
• コンピュータ断層撮影スキャン
• 肺機能検査
• 気管支鏡検査
• 世界のじん肺市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 専門クリニック
• 診断センター
• その他
• 世界のじん肺市場、アスベスト症のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 職業性アスベスト症
• 環境アスベスト症
• 潜在性アスベスト症
• 進行性アスベスト症
• 世界のじん肺市場、ベリリオシスのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 急性ベリリウム症
• 慢性ベリリウム症
• 職業性ベリリウム症
• 非職業性ベリリウム症
• 世界のじん肺市場、綿肺症のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 初期段階の綿肺症
• 進行期綿肺症
• 繊維労働者の綿肺症
• 間欠的曝露による綿肺症
• 世界のじん肺市場、炭鉱労働者じん肺のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 単純性CWP
• 複雑性CWP
• 表面炭鉱労働CWP
• 地下炭鉱労働者CWP
• 世界のじん肺市場、珪肺症のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 慢性珪肺症
• 加速性珪肺症
• 急性珪肺症
• 結節性珪肺症
• 世界のじん肺市場、その他のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 超硬合金じん肺
• タルク肺
• 鉄沈着症
• 混合粉じん性じん肺

第7章 地域別・国別分析

• 世界のじん肺市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のじん肺市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• じん肺市場：競合情勢
• じん肺市場：企業プロファイル
  • Pfizer Inc.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Bayer AG
  • Gilead Sciences

第31章 その他の大手企業と革新的企業

• Eli Lilly and Co.
• Boehringer Ingelheim
• Mylan Pharmaceuticals
• Bristol Myers Squibb
• Sino Biopharmaceutical Limited
• Aurobindo Pharmaceuticals
• Hikma Pharmaceuticals plc
• Kissei Pharmaceutical Co. Ltd.
• Veracyte Inc.
• Fidia Farmaceutici
• PharmaMar
• Verastem Inc.
• RS Oncology
• Melinta Therapeutics LLC
• Lupin

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• じん肺市場、2029年：新たな機会を提供する国
• じん肺市場、2029年：新たな機会を提供するセグメント
• じん肺市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Pneumoconiosis refers to a group of lung diseases resulting from the prolonged inhalation of certain types of dust, leading to inflammation and scarring in the lung tissue. This damage can hinder the lungs' ability to efficiently exchange oxygen, causing symptoms such as shortness of breath, persistent coughing, and reduced exercise tolerance.

The primary types of pneumoconiosis include asbestosis, berylliosis, byssinosis, coal workers' pneumoconiosis, silicosis, and others. Asbestosis is a chronic condition caused by the prolonged inhalation of asbestos fibers. Treatment options for pneumoconiosis include medications, oxygen therapy, pulmonary rehabilitation, and others. These treatments may be administered orally, through inhalation, or other methods, while diagnostic approaches involve chest X-rays, computed tomography (CT) scans, lung function tests, and bronchoscopy. Various healthcare providers, such as hospitals, specialty clinics, and diagnostic centers, serve as end users for these treatments and diagnostic procedures.

The pneumoconiosis market research report is one of a series of new reports from The Business Research Company that provides pneumoconiosis market statistics, including the pneumoconiosis industry global market size, regional shares, competitors with the pneumoconiosis market share, detailed pneumoconiosis market segments, market trends, and opportunities, and any further data you may need to thrive in the pneumoconiosis industry. This pneumoconiosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pneumoconiosis market size has grown strongly in recent years. It will grow from $5.18 billion in 2024 to $5.61 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to growing occupational exposure to coal dust, rising mining activities in unregulated regions, increasing neglect of worker health policies, growing delays in disease diagnosis, and rising cases of untreated respiratory issues.

The pneumoconiosis market size is expected to see strong growth in the next few years. It will grow to $7.62 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth projected for the forecast period is driven by an increased focus on occupational health standards, stricter enforcement of dust control regulations, more investments in worker safety initiatives, greater awareness of pneumoconiosis risks, and improved access to early diagnostic services. Key trends anticipated during the forecast period include advancements in lung imaging technologies, innovations in portable respiratory devices, developments in AI-driven disease detection, increased funding for research into dust-related health issues, and advancements in wearable air quality monitoring sensors.

The widespread prevalence of smoking is expected to drive the growth of the pneumoconiosis market. Smoking involves inhaling and exhaling the smoke from burning tobacco products such as cigarettes, cigars, or pipes, which releases harmful chemicals that negatively impact the lungs, heart, and overall health. The rising prevalence of smoking is linked to increasing nicotine dependence and continued tobacco use across various age groups. Smoking contributes to pneumoconiosis by raising the incidence of lung diseases related to smoking. For example, in June 2023, The Guardian reported that 14.5% of 14 to 17-year-olds in the UK had used vaping products in early 2023, an increase from 11.8% in 2022. This growing smoking rate is driving the pneumoconiosis market forward.

Increasing healthcare expenditures are expected to contribute to the growth of the pneumoconiosis market. Healthcare expenditures represent the total financial outlay on medical services, treatments, and health-related products by individuals, governments, and organizations. The rising healthcare spending is mainly due to the growing incidence of chronic diseases, which require ongoing treatment and management. These expenditures support pneumoconiosis care by financing early diagnoses, continuous medical care, respiratory therapy, and access to specialized treatments and medications. For example, the Office for National Statistics reported in May 2024 that healthcare spending in the UK grew by 5.6% from 2022 to 2023, a significant increase compared to the 0.9% growth in 2022. Therefore, rising healthcare expenditures will accelerate the pneumoconiosis market's growth.

Leading companies in the pneumoconiosis market are focusing on the development of targeted drugs, such as oral small molecule drugs, to offer innovative treatment options that improve disease management and enhance the quality of life for those affected by occupational lung diseases. Oral small molecule drugs are made from low molecular weight compounds that can be ingested, absorbed into the bloodstream, and designed to target specific biological processes or proteins to treat diseases. For instance, in March 2022, Sino Biopharmaceutical Limited launched TDI01 suspension, a novel oral small molecule drug targeting ROCK2 for pneumoconiosis treatment. This groundbreaking drug, currently undergoing clinical trials, aims to offer a much-needed therapeutic option for the 900,000 people with pneumoconiosis in China, a condition that previously had no effective treatment.

Major players in the pneumoconiosis market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Gilead Sciences, Eli Lilly and Co., Boehringer Ingelheim, Mylan Pharmaceuticals, Bristol Myers Squibb, Sino Biopharmaceutical Limited, Aurobindo Pharmaceuticals, Hikma Pharmaceuticals plc, Kissei Pharmaceutical Co. Ltd., Veracyte Inc., Fidia Farmaceutici, PharmaMar, Verastem Inc., RS Oncology, Melinta Therapeutics LLC, Lupin

North America was the largest region in the pneumoconiosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pneumoconiosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pneumoconiosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pneumoconiosis market consists of sales of protective equipment, diagnostic imaging systems, and therapeutic drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pneumoconiosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pneumoconiosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pneumoconiosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pneumoconiosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Asbestosis; Berylliosis; Byssinosis; Coal Workers Pneumoconiosis; Silicosis; Other Types
• 2) By Treatment: Medication; Oxygen Therapy; Pulmonary Rehabilitation; Other Treatments
• 3) By Route Of Administration: Oral; Inhalational; Other Route Of Administrations
• 4) By Diagnostic Method: Chest X-ray; Computed Tomography Scan; Lungfunction Tests; Bronchoscopy
• 5) By End Users: Hospitals; Specialty Clinics; Diagnostic Centers; Other End-users
• Sub Segments:
• 1) By Asbestosis: Pleural plaques; Diffuse pleural thickening; Rounded atelectasis; Lung cancer (as asbestos-related); Mesothelioma
• 2) By Berylliosis: Acute beryllium disease; Chronic beryllium disease (CBD); Hypersensitivity pneumonitis-like response
• 3) By Byssinosis: Acute byssinosis (early-stage); Chronic byssinosis; Work-related asthma
• 4) By Coal Workers' Pneumoconiosis (CWP): Simple CWP; Complicated CWP (Progressive Massive Fibrosis - PMF); Caplan's syndrome
• 5) By Silicosis: Acute silicosis; Accelerated silicosis; Chronic silicosis; Silicotuberculosis
• 6) By Other Types: Talcosis; Siderosis; Stannosis; Baritosis; Hard metal pneumoconiosis
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Bayer AG; Gilead Sciences
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pneumoconiosis Market Characteristics

3. Pneumoconiosis Market Trends And Strategies

4. Pneumoconiosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pneumoconiosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pneumoconiosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pneumoconiosis Market Growth Rate Analysis
• 5.4. Global Pneumoconiosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pneumoconiosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pneumoconiosis Total Addressable Market (TAM)

6. Pneumoconiosis Market Segmentation

• 6.1. Global Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Asbestosis
• Berylliosis
• Byssinosis
• Coal Workers Pneumoconiosis
• Silicosis
• Other Types
• 6.2. Global Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Oxygen Therapy
• Pulmonary Rehabilitation
• Other Treatments
• 6.3. Global Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Inhalational
• Other Route Of Administrations
• 6.4. Global Pneumoconiosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chest X-ray
• Computed Tomography Scan
• Lungfunction Tests
• Bronchoscopy
• 6.5. Global Pneumoconiosis Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Other End-users
• 6.6. Global Pneumoconiosis Market, Sub-Segmentation Of Asbestosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Occupational Asbestosis
• Environmental Asbestosis
• Latent Asbestosis
• Progressive Asbestosis
• 6.7. Global Pneumoconiosis Market, Sub-Segmentation Of Berylliosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Berylliosis
• Chronic Berylliosis
• Occupational Berylliosis
• Non-Occupational Berylliosis
• 6.8. Global Pneumoconiosis Market, Sub-Segmentation Of Byssinosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early-Stage Byssinosis
• Advanced-Stage Byssinosis
• Textile Workers Byssinosis
• Intermittent Exposure Byssinosis
• 6.9. Global Pneumoconiosis Market, Sub-Segmentation Of Coal Workers Pneumoconiosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Simple CWP
• Complicated CWP (Progressive Massive Fibrosis)
• Surface Miner CWP
• Underground Miner CWP
• 6.10. Global Pneumoconiosis Market, Sub-Segmentation Of Silicosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Silicosis
• Accelerated Silicosis
• Acute Silicosis
• Nodular Silicosis
• 6.11. Global Pneumoconiosis Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hard Metal Pneumoconiosis
• Talcosis
• Siderosis
• Mixed Dust Pneumoconiosis

7. Pneumoconiosis Market Regional And Country Analysis

• 7.1. Global Pneumoconiosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pneumoconiosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pneumoconiosis Market

• 8.1. Asia-Pacific Pneumoconiosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pneumoconiosis Market

• 9.1. China Pneumoconiosis Market Overview
• 9.2. China Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pneumoconiosis Market

• 10.1. India Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pneumoconiosis Market

• 11.1. Japan Pneumoconiosis Market Overview
• 11.2. Japan Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pneumoconiosis Market

• 12.1. Australia Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pneumoconiosis Market

• 13.1. Indonesia Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pneumoconiosis Market

• 14.1. South Korea Pneumoconiosis Market Overview
• 14.2. South Korea Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pneumoconiosis Market

• 15.1. Western Europe Pneumoconiosis Market Overview
• 15.2. Western Europe Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pneumoconiosis Market

• 16.1. UK Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pneumoconiosis Market

• 17.1. Germany Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pneumoconiosis Market

• 18.1. France Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pneumoconiosis Market

• 19.1. Italy Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pneumoconiosis Market

• 20.1. Spain Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pneumoconiosis Market

• 21.1. Eastern Europe Pneumoconiosis Market Overview
• 21.2. Eastern Europe Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pneumoconiosis Market

• 22.1. Russia Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pneumoconiosis Market

• 23.1. North America Pneumoconiosis Market Overview
• 23.2. North America Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pneumoconiosis Market

• 24.1. USA Pneumoconiosis Market Overview
• 24.2. USA Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pneumoconiosis Market

• 25.1. Canada Pneumoconiosis Market Overview
• 25.2. Canada Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pneumoconiosis Market

• 26.1. South America Pneumoconiosis Market Overview
• 26.2. South America Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pneumoconiosis Market

• 27.1. Brazil Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pneumoconiosis Market

• 28.1. Middle East Pneumoconiosis Market Overview
• 28.2. Middle East Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pneumoconiosis Market

• 29.1. Africa Pneumoconiosis Market Overview
• 29.2. Africa Pneumoconiosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pneumoconiosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pneumoconiosis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pneumoconiosis Market Competitive Landscape And Company Profiles

• 30.1. Pneumoconiosis Market Competitive Landscape
• 30.2. Pneumoconiosis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Gilead Sciences Overview, Products and Services, Strategy and Financial Analysis

31. Pneumoconiosis Market Other Major And Innovative Companies

• 31.1. Eli Lilly and Co.
• 31.2. Boehringer Ingelheim
• 31.3. Mylan Pharmaceuticals
• 31.4. Bristol Myers Squibb
• 31.5. Sino Biopharmaceutical Limited
• 31.6. Aurobindo Pharmaceuticals
• 31.7. Hikma Pharmaceuticals plc
• 31.8. Kissei Pharmaceutical Co. Ltd.
• 31.9. Veracyte Inc.
• 31.10. Fidia Farmaceutici
• 31.11. PharmaMar
• 31.12. Verastem Inc.
• 31.13. RS Oncology
• 31.14. Melinta Therapeutics LLC
• 31.15. Lupin

32. Global Pneumoconiosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pneumoconiosis Market

34. Recent Developments In The Pneumoconiosis Market

35. Pneumoconiosis Market High Potential Countries, Segments and Strategies

• 35.1 Pneumoconiosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pneumoconiosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pneumoconiosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer